Bag This Bargain Even Cheaper Than Director Coleman Did
May 17, 2021 at 11:27 AM EDT
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on May 12, Axsome Therapeutics Inc's Director, Mark Coleman, invested $29,075.00 into 500 shares of AXSM, for a cost per share of $58.15..